Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/1997
01/22/1997EP0754236A1 Reduction of endogenous seed protein levels in plants
01/22/1997EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
01/22/1997EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
01/22/1997EP0754227A1 Chimeric complement inhibitor proteins
01/22/1997EP0754226A1 Recombinant equine herpesviruses
01/22/1997EP0754223A1 Non-pathogenic strains of hiv-1
01/22/1997EP0754195A1 Btf2 complex proteins and uses thereof
01/22/1997EP0754194A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
01/22/1997EP0754193A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
01/22/1997EP0754192A1 Circularly permuted ligands and circularly permuted chimeric molecules
01/22/1997EP0754191A1 Novel receptor-type phosphotyrosine phosphatase-kappa
01/22/1997EP0754187A1 Growth arrest homeobox gene
01/22/1997EP0754059A1 Methods and compositions useful for inhibition of angiogenesis
01/22/1997EP0754054A1 Antirestenosis protein
01/22/1997EP0754050A1 Anti-gram-positive bacterial methods and materials
01/22/1997EP0754049A1 Anti-fungal methods and materials
01/22/1997EP0754048A1 Treatment of partial growth hormone insensitivity syndrome
01/22/1997EP0555438B1 Streptolysin o variants
01/22/1997EP0528858B1 Inhibitors of dipeptidyl-aminopeptidase type iv
01/22/1997EP0502979B1 Beta retinoic acid response elements compositions and assays
01/22/1997EP0502107B1 Type-b rotavirus cultures and uses thereof
01/22/1997EP0461200B1 Modified forms of reproductive hormones
01/22/1997CN1141061A Thrombopoietin
01/22/1997CN1141060A Haemophilus transferrin receptor genes
01/22/1997CN1141059A P53-binding polypeptides and polynucleotides encoding same
01/22/1997CN1141058A In situ modification and manipulation of stem cells of the central nervous system
01/22/1997CN1141000A Vaccine design and production
01/22/1997CN1140999A Anti-fungal methods and materials
01/22/1997CN1033866C Recombinant DNA-derived Bordetella toxin subunit analogs
01/21/1997US5596132 Induction of resistance to virus diseases by transformation of plants with a portion of a plant virus genome involving a read-through replicase gene
01/21/1997US5596089 Oligonucleotide probe and primers specific to bovine or porcine male genomic DNA
01/21/1997US5596088 DNA Encoding the human P2U receptor and null cells expressing P2U receptors
01/21/1997US5596082 Process for isolating lactoferrin and lactoperoxidase from milk and milk products, and products obtained by such process
01/21/1997US5596080 Heating in the presence of water
01/21/1997US5596079 Mimetics of senescent cell derived inhibitors of DNA synthesis
01/21/1997US5596072 Method of refolding human IL-13
01/21/1997US5596071 Bacillus thuringiensis toxins active against hymenopteran pests
01/21/1997US5595972 Polypeptides for signals
01/21/1997US5595969 Complexed with antiinflammatory agent, drug delivery
01/21/1997US5595913 Lipid fractionation
01/21/1997US5595912 Genetic vectors and rna codes
01/21/1997US5595903 Expression vectors, host cells
01/21/1997US5595901 Method for obtaining protective active and inactive adenylate cyclase from Bordetella parapertussis
01/21/1997US5595898 Cdna genetic sequences
01/21/1997US5595895 Efficient directional genetic cloning system
01/21/1997US5595888 Recombinant methods of making gamma interferon compositions
01/21/1997US5595887 Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
01/21/1997US5595886 Gene expression in eukaryotic cell, treatment of hemophilia
01/21/1997US5595885 Matrix metalloproteinase inhibitor peptides
01/21/1997US5595884 Papillomavirus E2 transactivation repressor proteins and DNA
01/21/1997US5595882 Angiotensin II type-1 receptor proteins and screening assays using such proteins or transformants expressing them
01/21/1997US5595880 DNA encoding an α2B adrenergic receptor and uses thereof
01/21/1997US5595877 Methods of producing nucleic acid ligands
01/21/1997US5595873 T. thermophila group I introns that cleave amide bonds
01/21/1997US5595872 Dna sequences, cells and expression vectors
01/21/1997US5595871 Detection and prevention of mycoplasma hominis infection
01/21/1997US5595869 Diagnostic methods for detecting lymphomas in humans
01/21/1997US5595741 Aminoalkylmaleimides and hapten and antigen derivatives derived therefrom as well as conjugates with peptides or proteins
01/21/1997US5595740 Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
01/21/1997US5595739 Hepatitis B virus mutants, reagents and methods for detection
01/21/1997US5595737 Leukocyte adhesion molecule, distinction between bound and shed molecule
01/21/1997US5595734 Compositions comprising ONCONASE (tm) and lovastatin
01/21/1997US5595733 Methods for protecting ZEA mays plants against pest damage
01/21/1997US5595732 Polyethylene-protein conjugates
01/21/1997US5595722 Transforming growth factor-beta activators
01/21/1997US5595721 Using antibodies directed to an antigen and radioactive labels
01/21/1997CA2097821C Ganoderma lucidum iy009 which produces proteoglycan(g009) having effect of enhancing antitumor immunity
01/21/1997CA1338874C Process for obtaining active proteins from a biologically inactive form
01/21/1997CA1338859C Expression system
01/16/1997WO1997001648A1 A novel human protein critical for hiv replication
01/16/1997WO1997001647A2 Dna sequences for identifying highly transmissible lineages of pseudomonas (burkholderia) cepacia
01/16/1997WO1997001642A1 Modified proteins and methods of their production
01/16/1997WO1997001640A2 Vaccines against hepatitis c
01/16/1997WO1997001638A1 Omp26 antigen from haemophilus influenzae
01/16/1997WO1997001637A1 Process for the microbial production of amino acids using recombinant micro-organisms with raised secretion rate
01/16/1997WO1997001636A2 Recombinant mistletoe lectin
01/16/1997WO1997001635A1 Bax omega protein and methods
01/16/1997WO1997001634A2 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp)
01/16/1997WO1997001633A1 Cytokine that induces apoptosis
01/16/1997WO1997001579A2 Somatostatin peptides
01/16/1997WO1997001578A1 Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides
01/16/1997WO1997001577A1 Ion channel
01/16/1997WO1997001576A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
01/16/1997WO1997001574A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3
01/16/1997WO1997001573A2 Early onset alzheimer's disease gene and gene products
01/16/1997WO1997001572A1 Sequences for production of 2,4-diacetylphloroglucinol and methods
01/16/1997WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
01/16/1997WO1997001352A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof
01/16/1997WO1997001351A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders
01/16/1997WO1997001350A1 Cd4-derived peptides that inhibit immune responses
01/16/1997WO1996037610A3 Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders
01/16/1997WO1996037607A3 Nucleic acid with a polymorphic domain of a b2 bradykinin receptor gene
01/16/1997WO1996036702A3 Soluble, active hepatitis c virus protease
01/16/1997WO1996034954A3 Biotin-binding containment systems
01/16/1997WO1996034887A3 Antisense peptides
01/16/1997WO1996034113A3 Methods for the identification of farnesyltransferase inhibitors
01/16/1997WO1996027677A3 Method of purification of recombinant viral vectors containing a therapeutic gene
01/16/1997DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD)
01/16/1997DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system
01/16/1997CA2226017A1 Cd4-derived peptides that inhibit immune responses